Equibles does not estimate personal net worth.
Get an email with a short summary when Relmada Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get RLMD alertsMaged Shenouda is recorded as CFO at Relmada Therapeutics, Inc. (RLMD). The newest filing on record that lists Maged Shenouda as CFO at Relmada Therapeutics, Inc. (RLMD) is dated April 17, 2026. Relmada Therapeutics, Inc. reported in an 8-K filed December 15, 2025 that Maged Shenouda was appointed Chief Financial Officer, effective January 1, 2025. Maged Shenouda has spoken on 20 earnings calls across 1 company, most recently for Relmada Therapeutics, Inc. on November 12, 2026. Relmada Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relmada Therapeutics, Inc. includes Sergio Traversa (CEO and Board Member), Charles J. Casamento (Chairman and Board Member), Paul Kelly (COO and Board Member) and 3 others.
“On behalf of Relmada Therapeutics, Inc: (the “Company”), I am pleased to offer you the position of Chief Financial Officer.”
“I'd like to build on Sergio and Bipin's comments by highlighting the substantial progress in manufacturing that should enable us to file the IMDs for NDV01 and Sopranolone by year-end.”
“Today, I'll spend a few minutes on Sopranolone and then provide you with an overview of our first quarter 2026 financial results. Sopranolone is a novel neurosteroid that modulates GABA, one of the most important neurotransmitters.”
“Today, I'll spend a few minutes on sopranalone and then provide you with an overview of our fourth quarter 2025 financial results. Because sopranalone modulates GABA, one of the most important neurotransmitters, it is defined as a GAMSA, or GABA-modulating steroid antagonist.”
“Today, I'll spend a few minutes on Sepranolone, and then provide you with an overview of our third quarter 2025 financials. Sepranolone is a member of a new subgroup of neurosteroids called GAMSAs or GABA modulating steroid antagonists.”
“I'll spend a few minutes on sepranolone and then provide you with an overview of our second quarter financial results. Sepranolone is a member of a new subgroup of neurosteroids called GAMSA, or GABA-A modulating steroid antagonists.”
Start not stated–present
Last confirmed April 17, 2026
Biotechnology · Healthcare
CFO
